Molecular mechanisms contributing to dendritic spine alterations in the prefrontal cortex of subjects with schizophrenia
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Postmortem studies have revealed reduced densities of dendritic spines in the dorsal lateral prefrontal cortex (DLPFC) of subjects with schizophrenia. However, the molecular mechanisms that might contribute to these alterations are unknown. Recent studies of the intracellular signals that regulate spine dynamics have identified members of the RhoGTPase family (e.g., Cdc42, Rac1, RhoA) as critical regulators of spine structure. In addition, Duo and drebrin are spine-specific proteins that are critical for spine maintenance and spine formation, respectively. In order to determine whether the mRNA expression levels of Cdc42, Rac1, RhoA, Duo or drebrin are altered in schizophrenia, tissue sections containing DLPFC area 9 from 15 matched pairs of subjects with schizophrenia and control subjects were processed for in situ hybridization. Expression levels of these mRNAs were also correlated with DLPFC spine density in a subset of the same subjects. In order to assess the potential influence of antipsychotic medications on the expression of these mRNAs, similar studies were conducted in monkeys chronically exposed to haloperidol or olanzapine. The expression of each of these mRNAs was lower in the gray matter of the subjects with schizophrenia compared to the control subjects, although only the reductions in Cdc42 and Duo remained significant after corrections for multiple comparisons. In addition, spine density was strongly correlated with the expression levels of both Duo (r=0.73, P=0.007) and Cdc42 (r=0.71, P=0.009) mRNAs. In contrast, the expression levels of Cdc42 and Duo mRNAs were not altered in monkeys chronically exposed to antipsychotic medications. In conclusion, reduced expression of Cdc42 and Duo mRNAs may represent molecular mechanisms that contribute to the decreased density of dendritic spines in the DLPFC of subjects with schizophrenia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Tissue analyses have found reductions in mRNAs for CDC42 and Duo that correlate with decreased spines134.”
From Stress weakens prefrontal networks: molecular insults to higher cognition (2015) · cites this paper as [134]
In the citing paper
“Loss of kalirin strongly correlates with spine loss in layer 3 prefrontal cortex neurons56.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [56]
In the citing paper
“Notably, the expression of KALRN (kalirin) mRNA was reduced in the DLPFC of individuals with schizophrenia, irrespective of antipsychotic treatment56.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [56]
Citations
Cites
Applied Linear Statistical Models
Ziegel, E. R., Neter, J., Wasserman, W., & Kutner, M. (1992) · Technometrics · doi:10.2307/1269588 · Cited by 9,907
Applied Linear Statistical Models
(1997) · Technometrics · doi:10.1080/00401706.1997.10485141 · Cited by 7,185
Rho GTPases and the Actin Cytoskeleton
Hall, A. (1998) · Science · doi:10.1126/science.279.5350.509 · Cited by 6,140
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Nobes, C. D., & Hall, A. (1995) · Cell · doi:10.1016/0092-8674(95)90370-4 · Cited by 4,412
DSM-IV: Diagnostic and Statistical Manual of Mental Disorders
Bell, C. C. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03520100096046 · Cited by 2,610
Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G. G., & Heyman, A. (2002) · Principles and Practice of Geriatric Psychiatry · doi:10.1002/0470846410.ch42(iii · Cited by 2,410
Decreased Dendritic Spine Density on Prefrontal Cortical Pyramidal Neurons in Schizophrenia
Glantz, L. A., & Lewis, D. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.1.65 · Cited by 1,636
Self-citationRHO GTPASES in neuronal morphogenesis
Luo, L. (2000) · Nature Reviews Neuroscience · doi:10.1038/35044547 · Cited by 986 · cited 1×
“10 In neurons, different members of the RhoGTPase family regulate different aspects of dendritic and spine morphology”
BackgroundHashimoto, T., Volk, D. W., Eggan, S. M., Mirnics, K., Pierri, J. N., Sun, Z., Sampson, A. R., & Lewis, D. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06315.2003 · Cited by 938
Self-citation
Cited by
Items 101–200 of 228
Rubio, M. D., Haroutunian, V. H., & Meador‐Woodruff, J. H. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.02.006 · Cited by 52
“Previous findings have suggested cytoskeletal dysfunction underlying dendritic spine loss (7, 14, 53, 54), supported by previous proteomic studies (55), we suggest a downstream molecular pathways that might lead to actin rearrangement in schizophrenia.”
InfluentialRapid Estradiol Modulation of Neuronal Connectivity and Its Implications for Disease
Srivastava, D. P., & Penzes, P. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00077 · Cited by 51
“Numerous clinical, epidemiological, and postmortem studies have strongly linked abnormal spine morphology, and disruptions in endocrine signaling with the pathogenesis of schizophrenia (Hill et al., 2006; Lewis and Sweet, 2009).”
BackgroundKalrnplays key roles within and outside of the nervous system
Mandela, P., Yankova, M. P., Conti, L. H., Ma, X., Grady, J., Eipper, B. A., & Mains, R. E. (2012) · BMC Neuroscience · doi:10.1186/1471-2202-13-136 · Cited by 46
“; licensee BioMed Centra Commons Attribution License (http://creativec reproduction in any medium, provided the or onset coronary artery disease [2-5], schizophrenia [6-9] and adult attention deficit-hyperactivity disorder [10].”
BackgroundModulation of behavior by scaffolding proteins of the post-synaptic density
Gao, C., Tronson, N. C., & Radulović, J. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.04.014 · Cited by 47
A novel role for the actin-binding protein drebrin in regulating opiate addiction
Martin, J. A., Werner, C. T., Mitra, S., Zhong, P., Wang, Z.-J., Gobira, P. H., Stewart, A. F., Zhang, J., Erias, K., Siemian, J. N., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12122-8 · Cited by 43
Abnormal kalirin signaling in neuropsychiatric disorders
Remmers, C., Sweet, R. A., & Penzes, P. (2014) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.12.006 · Cited by 42
“In a postmortem study, kalirin mRNA was found to be reduced in the DLPFC of schizophrenia patients, irrespective of antipsychotic treatment (Hill et al., 2006).”
BackgroundSchizophrenia in a patient with subtelomeric duplication of chromosome 22q
Failla, P., Romano, C., Alberti, A., Vasta, A., Buono, S., Castiglia, L., Luciano, D., Benedetto, D. D., Fichera, M., & Galesi, O. (2007) · Clinical Genetics · doi:10.1111/j.1399-0004.2007.00819.x · Cited by 43
Diacylglycerol kinase β accumulates on the perisynaptic site of medium spiny neurons in the striatum
Hozumi, Y., Fukaya, M., Adachi, N., Saito, N., Otani, K., Kondo, H., Watanabe, M., & Goto, K. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06547.x · Cited by 44
“Psychiatric diseases, such as mood disorders and schizophrenia, are thought to accompany the dysgenesis and dysfunction of dendritic spines (Law et al., 2004; Critchlow et al., 2006; Hill et al., 2006).”
BackgroundMolecular design of a therapeutic LSD analogue with reduced hallucinogenic potential
Tuck, J. R., Dunlap, L. E., Khatib, Y. A., Hatzipantelis, C. J., Novak, S. W., Rahn, R. M., Davis, A. R., Mosswood, A., Vernier, A. M. M., Fenton, E. M., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2416106122 · Cited by 50
Russell, T. A., Blizinsky, K. D., Cobia, D. J., Cahill, M. E., Xie, Z., Sweet, R. A., Duan, J., Gejman, P. V., Wang, L., Csernansky, J. G., et al. (2014) · Nature Communications · doi:10.1038/ncomms5858 · Cited by 37
“Post-mortem analyses of brains from schizophrenia patients also demonstrate a reduction in the density of pyramidal neuron dendritic spines in several regions of the cortex, including the dorsolateral prefrontal cortex, the anterior cingulate cortex, and the superior temporal gyrus 23, 61 .”
Is Schizophrenia the Price of Human Central Nervous System Complexity?
Dean, B. (2009) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670802534416 · Cited by 39
“Supporting this argument are recent findings that show that surrogate markers of synaptic density are consistently decreased in the cortex of subjects with schizophrenia [100,101].”
ResultNeuregulin1 signaling promotes dendritic spine growth through kalirin
Cahill, M. E., Remmers, C. L., Jones, K. A., Xie, Z., Sweet, R. A., & Penzes, P. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12330 · Cited by 43
Kalrn promoter usage and isoform expression respond to chronic cocaine exposure
Mains, R. E., Kiraly, D. D., Eipper-Mains, J. E., Ma, X., & Eipper, B. A. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-20 · Cited by 42
“Linkage analyses identified Kalrn as a major risk factor for coronary artery disease and stroke [1-3], as well as for schizophrenia and adult attention-deficit/hyperactivity disorder [4-6].”
BackgroundRussell, T. A., Grubisha, M. J., Remmers, C. L., Kang, S. K., Forrest, M. P., Smith, K. R., Kopeikina, K. J., Gao, R., Sweet, R. A., & Penzes, P. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.10.024 · Cited by 41
“Notably, postmortem studies found kalirin mRNA and levels of the kalirin-7 (Kal7) protein isoform to be reduced in the prefrontal cortex (8, 9), while kalirin-9 (Kal9) was increased in the auditory cortex in subjects with SZ (10), suggesting a role for kalirin in SZ pathophysiology.”
BackgroundBrosda, J., Dietz, F., & Koch, M. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.07.008 · Cited by 37
“Similar behavioral and neurostructural findings were detected in schizophrenic patients and in post mortem brains of schizophrenic patients, respectively (Braff et al., 2001; Glantz and Lewis, 2000; Hill et al., 2006; Krystal et al., 2003; Rosoklija et al., 2000; Selemon and Goldman-Rakic, 1999; Steinpreis, 1996).”
BackgroundResultLiang, W., Huang, Y., Tan, X.-M., Wu, J., Duan, J., Zhang, H.-P., Yin, B.-M., Li, Y.-F., Zheng, P., Wei, H., et al. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s225982 · Cited by 28
“Consistent with our hypothesis, previous studies have observed a marked reduction in dendritic spines in human postmortem brain tissue from schizophrenia patients.(33,34) Further studies are required to investigate how the gut microbiota modulates the genes related to dendritic spine development.”
ResultKalirin Signaling: Implications for Synaptic Pathology
Penzes, P., & Remmers, C. L. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8223-z · Cited by 44
“estingly, kalirin loss correlated with spine loss on layer 3 PFC neurons [27].”
Datta, D., & Arnsten, A. F. T. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00505 · Cited by 38
Bircher, J. E., & Koleske, A. J. (2021) · Journal of Cell Science · doi:10.1242/jcs.248393 · Cited by 41
“For instance, mRNA levels of KALRN are significantly decreased in the dorsolateral prefrontal cortex of SCZ patients (Hill et al., 2006).”
BackgroundHippocampal phenotypes in kalirin-deficient mice
Xie, Z., Cahill, M. E., Radulovic, J., Wang, J., Campbell, S. L., Miller, C. A., Sweatt, J. D., & Penzes, P. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2010.08.005 · Cited by 34
“Reduced expression of kalirin mRNA has been detected in the prefrontal cortex of subjects with schizophrenia (Hill et al., 2006; Narayan et al., 2008), and these reduced kalirin transcript levels correlated strongly with spine loss in the Xie et al.”
BackgroundInfluentialAltered prefrontal cortical MARCKS and PPP1R9A mRNA expression in schizophrenia and bipolar disorder
Konopaske, G. T., Subburaju, S., Coyle, J. T., & Benes, F. M. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.02.005 · Cited by 38
de Curtis, I. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00307 · Cited by 33
“, 2004) Unknown: KO affects inhibitory input and PV+ cells Kalirin-7 KLRN Rac GEF Schizophrenia (Hill et al., 2006) Dendritic growth; potentiation of excitatory postsynaptic terminals PAK3 PAK3 Effector of Rac/Cdc42 X-linked mental retardation (Allen et al.”
Folsom, T. D., THURAS, P. D., & Fatemi, S. H. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.04.012 · Cited by 33
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript subjects with schizophrenia (Hill et al., 2006).”
BackgroundInfluentialDiacylglycerol kinase β in neurons: Functional implications at the synapse and in disease
Hozumi, Y., & Goto, K. (2012) · Advances in Biological Regulation · doi:10.1016/j.jbior.2012.03.003 · Cited by 30
Cooper, M. A., & Koleske, A. J. (2014) · Journal of Comparative Neurology · doi:10.1002/cne.23615 · Cited by 29
“Intriguingly, Kalirin-7 is known to be downregulated in the brains of schizophrenia patients (Hill et al., 2006; Narayan et al., 2008).”
BackgroundFrontal cortical synaptic communication is abnormal in Disc1 genetic mouse models of schizophrenia
Holley, S. M., Wang, E. A., Cepeda, C., Jentsch, J. D., Ross, C. A., Pletnikov, M. V., & Levine, M. S. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.02.007 · Cited by 33
“Furthermore, the inputs to and the morphology of cortical layer II/III pyramidal cells have been shown to undergo pathophysiological alterations in SZ (Lewis and Gonzalez-Burgos, 2000; Pierri et al., 2001; Hill et al., 2006).”
Pinacho, R., Vila, È., Prades, R., Tarragó, T., Castro, E., Ferrer, I., & Ramos, B. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.04.024 · Cited by 30
“Moreover, previous studies have also reported a reduction in RAC1 gene expression in schizophrenia (Hayashi-Takagi et al., 2010; Hill et al., 2006) further supporting the case for a possible contribution of RAC1 to the pathophysiology of schizophrenia.”
Synaptic dysfunction in schizophrenia
Mısır, E., & Akay, G. G. (2023) · Synapse · doi:10.1002/syn.22276 · Cited by 34
“Kalirin-7 mRNA expression and protein levels in the prefrontal cortex were also decreased in Scz patients (Hill et al., 2006; Mould et al., 2022).”
BackgroundBERNSTEIN, H., Sahin, J., Smalla, K., Gundelfinger, E. D., Bogerts, B., & KREUTZ, M. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.05.038 · Cited by 28
Identification of Kalirin-7 as a Potential Post-Synaptic Density Signaling Hub
Kiraly, D. D., Stone, K. L., Colangelo, C. M., Abbott, T., Wang, Y., Mains, R. E., & Eipper, B. A. (2011) · Journal of Proteome Research · doi:10.1021/pr200088w · Cited by 26
Umetsu, R., Tanaka, M., Nakayama, Y., Kato, Y., Ueda, N., Nishibata, Y., Hasegawa, S., Matsumoto, K., Takeyama, N., Iguchi, K., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.764279 · Cited by 30
“, 2010), schizophrenia (Hill et al., 2006; Hayashi-Takagi et al., 2010; Bradshaw and Porteous, 2012), and adult attention-deficit/ hyperactivity disorder (Lesch et al.”
BackgroundSeabra, G., de Almeida, V., Reis‐de‐Oliveira, G., Crunfli, F., Antunes, A. S. L. M., & Martins‐de‐Souza, D. (2020) · Scientific Reports · doi:10.1038/s41598-020-69543-5 · Cited by 27
Fernández‐Teruel, A., Oliveras, I., Cañete, T., Río-Álamos, C., Tapias-Espinosa, C., Sampedro-Viana, D., Sánchez-González, A., Sanna, F., Torrúbia, R., González‐Maeso, J., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.09.042 · Cited by 27
Investigation of the involvement of MIR185 and its target genes in the development of schizophrenia
Forstner, A. J., Basmanav, F. B., Mattheisen, M., GROUP Investigators, Böhmer, A. C., Hollegaard, M. V., Janson, E., Strengman, E., Priebe, L., Degenhardt, F., et al. (2014) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.130189 · Cited by 29
Yao, W., Zhou, P., Yan, Q., Wu, X., Xia, Y., Li, W., Li, X., & Zhu, F. (2023) · Viruses · doi:10.3390/v15010168 · Cited by 25
“Postmortem studies indicate that RAC1 is significantly decreased in the gray matter of subjects with schizophrenia [73].”
BackgroundResultMita, N., He, X., Sasamoto, K., Mishiba, T., & Ohshima, T. (2014) · Cerebral Cortex · doi:10.1093/cercor/bhu264 · Cited by 25
“Most pronounced decreased dendritic spine density was found in the prefrontal cortex in schizophrenia patients (Hill et al. 2006).”
Backgroundde Bartolomeis, A., Vellucci, L., Simone, G. D., Mazza, B., Barone, A., & Ciccarelli, M. (2023) · Cells · doi:10.3390/cells12040574 · Cited by 23
Kroeze, Y., Oti, M., van Beusekom, E., Cooijmans, R. H. M., van Bokhoven, H., Kolk, S. M., Homberg, J. R., & Zhou, H. (2017) · Cerebral Cortex · doi:10.1093/cercor/bhw407 · Cited by 23
Sánchez-González, A., Thougaard, E., Tapias-Espinosa, C., Cañete, T., Sampedro-Viana, D., Saunders, J. M., Toneatti, R., Tobeña, A., González‐Maeso, J., Aznar, S., et al. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.01.006 · Cited by 24
“The dendritic spine alterations in cortical pyramidal neurons in schizophrenia brains have been related to the cognitive symptoms of the disorder (Glantz and Lewis, 2000;Hill et al., 2006;Black et al., 2004).”
BackgroundEgbujo, C. N., Sinclair, D., Borgmann‐Winter, K. E., Arnold, S. E., Turetsky, B. I., & Hahn, C.-G. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.07.026 · Cited by 21
“Given multiple reports of abnormal synaptic density and protein expression in various cortical and limbic brain regions in schizophrenia (Glantz and Lewis, 1997, 2000; Hill et al., 2006; Karson et al., 1999; Rosoklija et al., 2000; Sweet et al., 2009; Thompson et al., 1998), we hypothesized that altered synaptic conne…”
BackgroundInfluentialReplicated genetic evidence supports a role for HOMER2 in schizophrenia
Gilks, W. P., Allott, E. H., Donohoe, G. J., Cummings, E., Gill, M., Corvin, A. P., & Morris, D. W. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.11.003 · Cited by 21
Zhao, K., Shi, Y., & So, H. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020234 · Cited by 20
“As for another candidate target, RhoA, a study showed reduced mRNA expression of RhoA in dorsolateral prefrontal cortex of SCZ subjects compared to controls [31].”
BackgroundThomas, R. A., Gibon, J., Chen, C. X. ‐., Chierzi, S., Soubannier, V., Baulac, S., Séguéla, P., Murai, K. K., & Barker, P. A. (2018) · eNeuro · doi:10.1523/eneuro.0185-18.2018 · Cited by 23
“Growing evidence suggests dysregulation of RhoA signaling contributes to the etiology of multiple psychiatric disorders, including schizophrenia (Hill et al., 2006).”
BackgroundA Novel Long Non-coding RNA, durga Modulates Dendrite Density and Expression of kalirin in Zebrafish
Sarangdhar, M. A., Chaubey, D., Bhatt, A., Monisha, K. M., Kumar, M., Ranjan, S., & Pillai, B. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00095 · Cited by 24
“…and Industrial Research (CSIR), Institute of Genomics and Integrative Biology (IGIB), New Delhi, India, 2Academy of Scientific and Innovative Research (AcSIR), New Delhi, India Edited by: Philip Washbourne, University of Oregon, USA Reviewed by: Christian Gonzalez-Billault, University of…”
BackgroundPAK1 Protein Expression in the Auditory Cortex of Schizophrenia Subjects
Deo, A. J., Goldszer, I. M., Li, S., DiBitetto, J. V., Henteleff, R. A., Sampson, A. R., Lewis, D. A., Penzes, P., & Sweet, R. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059458 · Cited by 22
Self-citationA new use for long-term frozen brain tissue: Golgi impregnation
Meléndez‐Ferro, M., Pérez‐Costas, E., & Roberts, R. C. (2008) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2008.08.021 · Cited by 19
“, 2007), and also in diseases in which such “macroscopic” alterations of neurons do not occur or are much subtler, such as schizophrenia and depression (Glantz and Lewis, 2000; Hill et al., 2006).”
BackgroundA Novel Bio-Psychosocial-Behavioral Treatment Model in Schizophrenia
Kim, Y., Choi, J., & Park, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040734 · Cited by 21
“One potentially promising therapeutic target are spine-specific kinases, since they regulate spine size, number and functions [72,73].”
BackgroundMiller, M. B., Yan, Y., Machida, K., Kiraly, D. D., Levy, A. D., Wu, Y. I., Lam, T. T., Abbott, T., Koleske, A. J., Eipper, B. A., et al. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00076 · Cited by 18
Kalirin-7 is a Key Player in the Formation of Excitatory Synapses in Hippocampal Neurons
Ma, X. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.148 · Cited by 17
“Decreased Kalirin levels are accompanied by a decrease in spine density in the cortex of schizophrenic patients[70,71,102].”
BackgroundShortall, S. E., Negm, O. H., Fowler, M. J., Fairclough, L. C., Tighe, P. J., Wigmore, P. M., & King, M. V. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0940-0 · Cited by 23
Genetic polymorphism and neuroanatomical changes in schizophrenia
Năstase, M. G., Vlaicu, I., & Trifu, S. C. (2022) · Romanian Journal of Morphology and Embryology · doi:10.47162/rjme.63.2.03 · Cited by 22
Functional investigation of a schizophrenia GWAS signal at the CDC42 gene
Gilks, W. P., Hill, M., Gill, M., Donohoe, G. J., Corvin, A. P., & Morris, D. W. (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2012.666359 · Cited by 15
“By using in situ hybridisation, Hill et al. (2006) identifi ed a reduction of CDC42 expression in schizophrenia, independent of the effects of antipsychotic medication.”
BackgroundInfluentialMartínez-Torres, N. I., Vázquez-Hernández, N., Martín-Amaya-Barajas, F. L., Flores-Soto, M. E., & González‐Burgos, I. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173883 · Cited by 17
Goikolea-Vives, A., & Stolp, H. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158220 · Cited by 16
Sabaie, H., Gharesouran, J., Asadi, M. R., Farhang, S., Ahangar, N. K., Brand, S., Arsang‐Jang, S., Dastar, S., Taheri, M. N., & Rezazadeh, M. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-00918-5 · Cited by 17
“2011), have altered expression levels in individuals with SCZ (Hill et al. 2006; Ide and Lewis 2010).”
BackgroundDendritic spine morphology and dynamics in health and disease
Webb, D. J., Lee, S. N., & Zhang, H. (2015) · Cell Health and Cytoskeleton · doi:10.2147/chc.s82214 · Cited by 20
“Cdc42 mRNA levels are lower in patients with schizophrenia, whereas mRNA levels of the Cdc42 effector protein 3 (Cdc42EP3) are increased.(142,144) Cdc42EP3 binds septins and regulates septin organization, and Cdc42 inhibits this interaction.”
Román, C., Egert, L., & Benedetto, B. D. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14900 · Cited by 16
Hayashi‐Takagi, A., Barker, P. B., & Arika, S. (2011) · Communicative & Integrative Biology · doi:10.4161/cib.4.2.14492 · Cited by 18
Alterations in Prefrontal Cortical Circuitry and Cognitive Dysfunction in Schizophrenia
Lewis, D. A., & Glausier, J. R. (2016) · Nebraska Symposium on Motivation/The Nebraska symposium on motivation · doi:10.1007/978-3-319-30596-7_3 · Cited by 15
Self-citationQuick Golgi method: modified for high clarity and better neuronal anatomy.
Patro, N., Kumar, K., & Patro, I. K. (2013) · PubMed · Cited by 17
Excess Wnt in neurological disease
Pascual, D. M., Rizi, D. J., Kaur, H., & Marcogliese, P. C. (2025) · Biochemical Journal · doi:10.1042/bcj20240265 · Cited by 18
Duan, J. (2015) · Neuroscience Bulletin · doi:10.1007/s12264-014-1488-2 · Cited by 15
Bolton, M. M., Heaney, C. F., Murtishaw, A. S., Sabbagh, J. J., Magcalas, C. M., & Kinney, J. W. (2014) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2014.10.001 · Cited by 17
“For example, in schizophrenia, altered kalirin has been found in the brain (Hill et al., 2006; Sweet et al., 2008; Penzes and Remmers, 2012), and mutations of the kalirin gene have been found to induce changes relevant to schizophrenia in animal model systems (Ma et al., 2008; Cahill et al., 2009).”
BackgroundLong‐term perturbation of spine plasticity results in distinct impairments of cognitive function
VanLeeuwen, J., & Penzes, P. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07899.x · Cited by 15
Kimoto, S., Hashimoto, T., Berry, K. J., Tsubomoto, M., Yamaguchi, Y., Enwright, J. F., Chen, K., Kawabata, R., Kikuchi, M., Kishimoto, T., et al. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01274-9 · Cited by 14
“First, in our previous studies, none of the comorbid factors assessed, including substance abuse/dependence at the time of death; use of antidepressants, benzodiazepine/anticonvulsant or antipsychotics at the time of death; or death by suicide had significant effects on actin- or OXPHOS-related transcript levels in th…”
BackgroundSelf-citationJacobi, A. A., Halawani, S. M., Lynch, D. R., & Lin, H. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.10.055 · Cited by 14
Disruption of the gene regulatory programme in neurodevelopmental disorders
Griffin, A., Mahesh, A., & Tiwari, V. K. (2022) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2022.194860 · Cited by 15
In vivo study sheds new light on the dendritic spine pathology hypothesis of schizophrenia
Li, W., Lv, L., & Luo, X. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01449-2 · Cited by 14
Xu, M., Liu, Y., Huang, Y., Wang, J., Yan, J., Zhang, L., & Zhang, C. (2018) · Aging · doi:10.18632/aging.101589 · Cited by 12
“This reduced expression of CDC42 may contribute to the decreased density of dendritic spines and cognitive dysfunction observed in schizophrenia [36-38].”
BackgroundChen, M. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.08.013 · Cited by 13
Romay-Tallón, R., Dopeso‐Reyes, I. G., Lussier, A. L., Kalynchuk, L. E., & Caruncho, H. J. (2010) · Neural Plasticity · doi:10.1155/2010/130429 · Cited by 12
Chen, M., Tsai, F., Lee, M., & Lin, Y.-Y. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.06.003 · Cited by 12
“A postmortem study also suggested that reduction of Cdc42 mRNA expression in the dorsal lateral prefrontal cortexmight represent a molecular mechanism that contributes to the decreasing of dendritic spines density in schizophrenic patients (Hill et al., 2006).”
BackgroundKalirin as a Novel Treatment Target for Cognitive Dysfunction in Schizophrenia
Mould, A. W., Al‐Juffali, N., von Delft, A., Brennan, P. E., & Tunbridge, E. M. (2021) · CNS Drugs · doi:10.1007/s40263-021-00884-z · Cited by 12
“n = 15 matched controls) [62] and protein (n = 36 patients vs.”
BackgroundDysregulation of Synaptic Plasticity Markers in Schizophrenia
Keshri, N., & Nandeesha, H. (2022) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-022-01068-2 · Cited by 11
Cerebrospinal Fluid Protein Markers Indicate Neuro-Damage in SARS-CoV-2-Infected Nonhuman Primates
Maity, S., Mayer, M. G., Shu, Q., Hellmers, L., Bao, D., Blair, R. V., He, Y., Lyon, C. J., Hu, Y., Fischer, T., et al. (2023) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2023.100523 · Cited by 12
Konopaske, G. T., & Coyle, J. T. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-398270-4.00039-2 · Cited by 12
Cornelius, J., Rottner, K., Körte, M., & Michaelsen‐Preusse, K. (2021) · Cells · doi:10.3390/cells10071835 · Cited by 11
“, in schizophrenic patients, in which expression levels of both Cttn and Cdc42 were found to be significantly reduced [50,51].”
BackgroundLow accumulation of drebrin at glutamatergic postsynaptic sites on GABAergic neurons
Hanamura, K., Mizui, T., Kakizaki, T., Roppongi, R. T., Yamazaki, H., Yanagawa, Y., & Shirao, T. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.06.043 · Cited by 12
Luo, X., Chen, S. X., Li, X., Chen, J., Shi, Y., & Zhao, H. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00175 · Cited by 11
Flores, C., Bhardwaj, S. K., Labelle‐Dumais, C., & Srivastava, L. K. (2008) · Synapse · doi:10.1002/syn.20584 · Cited by 16
The Neuroprotective Potential of Vitamin D3
Pietruszkiewicz, J., Mrozek, K., Zwierz, M., Wińska, A., Suprunowicz, M., Oracz, A. J., & Waszkiewicz, N. (2025) · Nutrients · doi:10.3390/nu17203202 · Cited by 18
“Experimental models show that vitamin D regulates the expression of genes involved in synaptic remodeling, including neuromodulin and drebrin, whose abnormal expression has been reported in schizophrenia [45,46].”
Krivinko, J. M., Erickson, S. L., Abrahamson, E. E., Wills, Z. P., Ikonomović, M. D., Penzes, P., & Sweet, R. A. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.02.006 · Cited by 9
“Kalirin mutations, gene expression, and protein levels have been associated with risk for the psychotic disorder schizophrenia (Deo et al., 2011; Hill et al., 2006; Kushima et al., 2010; Rubio et al., 2012).”
Shibata, H., Yamamoto, K., Sun, Z., Oka, A., Inoko, H., Arinami, T., Inada, T., Ujike, H., Itokawa, M., Tochigi, M., et al. (2013) · Psychiatric Genetics · doi:10.1097/ypg.0b013e32835fe4f1 · Cited by 12
“Both molecules are involved in dendritic spine development and show significant changes in expression level in the dorsolateral prefrontal cortex of patients with schizophrenia (Hill et al., 2006; Ide and Lewis, 2010).”
BackgroundGenetic Variant ofKalirinGene Is Associated with Ischemic Stroke in a Chinese Han Population
Li, H., Yu, S., Wang, R., Sun, Z., Zhou, X., Zheng, L., Yin, Z., Zhang, X., & Sun, Y. (2017) · BioMed Research International · doi:10.1155/2017/6594271 · Cited by 8
“The KALRN gene has been linked to schizophrenia [40, 41] and adult attention deficit-hyperactivity disorder [42].”
BackgroundRole of Cdk5 in Kalirin7-Mediated Formation of Dendritic Spines
Li, M.-X., Qiao, H., Zhang, M., & Ma, X. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02771-y · Cited by 10
Cytoskeletal changes in diseases of the nervous system
Suchowerska, A. K., & Fath, T. (2014) · Frontiers in Biology · doi:10.1007/s11515-014-1290-6 · Cited by 11
Dienel, S. J., Bazmi, H. H., & Lewis, D. A. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.05.016 · Cited by 9
Self-citationAge‐dependent increase in Kalirin‐9 and Kalirin‐12 transcripts in human orbitofrontal cortex
Grubisha, M. J., Lin, C., Tseng, G. C., Penzes, P., Sibille, E. L., & Sweet, R. A. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13351 · Cited by 8
“Similarly, KAL isoform expression is reported to be altered in both schizophrenia and Alzheimer disease (Hill et al., 2006; Youn et al., 2007; Deo et al., 2012; Murray et al., 2012; Rubio et al., 2012), illnesses that manifest at either extreme of the adult lifespan and that are characterized by alterations in dendrit…”
BackgroundLaRese, T. P., Yan, Y., Eipper, B. A., & Mains, R. E. (2017) · BMC Neuroscience · doi:10.1186/s12868-017-0363-2 · Cited by 9
Découvertes récentes sur la fonction et la plasticité des voies dopaminergiques du cerveau
Thibault, D., Kortleven, C., Fasano, C., Bo, G. D., & Trudeau, L. (2010) · médecine/sciences · doi:10.1051/medsci/2010262165 · Cited by 12
Quiccione, M. S., Tirozzi, A., Cassioli, G., Morelli, M., Costanzo, S., Pepe, A., Bracone, F., Magnacca, S., Cerletti, C., Licastro, D., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910317 · Cited by 7
Rodríguez-Vega, A., Dutra-Tavares, A. C., de Souza, T. P., Semeão, K. A., Filgueiras, C. C., Ribeiro‐Carvalho, A., Manhães, A. C., & Abreu‐Villaça, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914634 · Cited by 7
“In accordance with these findings, Gap43 [144] and Dbn1 [145] mRNA and Marcks protein levels [146,147] were previously shown to be deregulated in the prefrontal cortex of SCHZ patients.”
Scaling of smaller pyramidal neuron size and lower energy production in schizophrenia
Schoonover, K. E., Miller, N. E., Fish, K. N., & Lewis, D. A. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106394 · Cited by 10
“…dendritic spine density of L3PN in schizophrenia; indeed, expression levels of transcripts in actin-regulating pathways are altered in DLPFC L3PNs in schizophrenia (Datta et al., 2017; Datta et al., 2015) and correlated with lower dendritic spine density (Hill et al., 2006; Ide and Lewis, 2010).”
Self-citationHomozygous and Heterozygous Reeler Mouse Mutants
Tueting, P. A., Pinna, G., & Costa, E. (2008) · Springer eBooks · doi:10.1007/978-0-387-76761-1_20 · Cited by 7
“Importantly, dendritic spine density in prefrontal cortical pyramidal neurons is decreased in schizophrenia (Glantz and Lewis, 2000; Hill et al., 2006).”
BackgroundGroß, I., Brandt, N., Vonk, D., Köper, F., Wöhlbrand, L., Rabus, R., Witt, M., Heep, A., Plösch, T., Hipp, M. S., et al. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.797588 · Cited by 7
Classification and function of GABAergic interneurons of the mammalian cerebral cortex
Zaitsev, A. V. (2013) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s1990747813040090 · Cited by 7
Dong, Y., Wang, S., Qiu, Y., Su, Q., Sun, X., Li, M., & Li, J. (2025) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2025.107711 · Cited by 3
Tomita, Y., Toriumi, K., Miyashita, M., Suzuki, K., Kawaji, H., Itokawa, M., & Arai, M. (2025) · Schizophrenia · doi:10.1038/s41537-025-00706-x · Cited by 5
“The dysregulation of these terms has been implicated in the pathogenesis of schizophrenia 77 – 79 .”
Smith, S. S., Benanni, S., Jones, Q., Kenney, L., & Evrard, M. R. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148929 · Cited by 3
“This reduction in spine density was correlated with reductions in mRNA of Kalirin (Hill et al., 2006) and CDC42, which regulates actin polymerization that is required for spine maturation (Scott et al., 2003).”
The role and molecular mechanisms of the early growth response 3 gene in schizophrenia
He, Q., Li, R., Zhong, N., Ma, J., Nie, F., & Zhang, R. (2024) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32969 · Cited by 4
“The RhoA mRNA expression level was altered in schizophrenia subjects (Hill et al., 2006), and rare variants of SHANK2 were associated with schizophrenia (Peykov et al., 2015).”
Background
Metadata
- Authors
- Hill, J. J., Hashimoto, T., & Lewis, D. A.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Lewis, D A
- Venue
- Molecular Psychiatry
- Published
- 2006-01-10
- Volume
- 11
- Issue
- 6
- Pages
- 557-566
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2048571739
- Cited by
- 228
- References
- 51
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 4 · 2023: 9 · 2022: 11 · 2021: 13 · 2020: 8 · 2019: 12 · 2018: 9 · 2017: 12 · 2016: 11 · 2015: 17 · 2014: 13 · 2013: 13 · 2012: 15
- FWCI
- 5.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (P50 MH-45156, T32 MH18273, T32MH018273, P50MH045156)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- schizophrenia, dendritic spines, dorsolateral prefrontal cortex, Cdc42, Rac1, RhoA, duos, drebrin, mRNA expression, spine density, antipsychotic drugs, haloperidol, olanzapine, chronic drug exposure, postmortem brain
- MeSH terms
- Adult, Animals, Haplorhini, Female, Humans, Male, Middle Aged, Neuropeptides, RNA, Messenger, Schizophrenia, Antipsychotic Agents, Matched-Pair Analysis, Protein Serine-Threonine Kinases, Prefrontal Cortex, Guanine Nucleotide Exchange Factors, rho GTP-Binding Proteins, rhoA GTP-Binding Protein, cdc42 GTP-Binding Protein, rac1 GTP-Binding Protein, Gene Expression Profiling, Dendritic Spines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.